HSDT Earnings Date: Nov 17, 2026 (Estimated) — Solana Company
NASDAQ · Healthcare · Medical Devices
Updated
When is HSDT's next earnings date?
Solana Company (HSDT) is expected to report Q3 2026 earnings on Tuesday, November 17, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.02 on revenue of $2.9M.
How did HSDT do in its last earnings report?
In its most recent report on Aug 14, 2026 (Q2 2026), Solana Company posted EPS of -$0.38 versus the -$0.02 estimate, a miss of 1800.0%. Revenue was $2.5M against a $3.5M estimate. The stock's 1-day post-earnings move was -2.4%.
How much does HSDT stock move after earnings?
HSDT beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.4% (up or down) in the day after earnings.
About Solana Company
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | Q2 2026 | -0.02 | -0.38 | -1800.00% | $2.5M | ❌ Miss | -2.35% | +23.53% | +30.00% |
| 2026-05-15 | Q1 2026 | -0.70 | -1.30 | -85.71% | $3.6M | ❌ Miss | -5.22% | -0.43% | -29.13% |
| 2026-03-30 | Q4 2025 | -26.50 | 4.25 | +116.04% | $5.2M | ✅ Beat | -6.99% | -1.61% | +6.45% |
| 2025-11-18 | Q3 2025 | -50.50 | -32.89 | +34.87% | $697,000 | ✅ Beat | -6.00% | -10.25% | -27.75% |
| 2025-08-14 | Q2 2025 | -127.50 | -79.73 | +37.47% | $43,000 | ✅ Beat | +0.17% | -0.50% | +203.49% |
| 2025-03-25 | Q4 2024 | -0.92 | -1.02 | -10.87% | $152,000 | ❌ Miss | -2.79% | +6.66% | -28.09% |
| 2024-08-12 | Q2 2024 | -0.50 | -0.64 | -28.00% | $182,000 | ❌ Miss | -4.50% | -9.69% | +1.69% |
| 2024-05-13 | Q1 2024 | -3.87 | -3.08 | +20.41% | $135,000 | ✅ Beat | -7.54% | -18.81% | -34.81% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q4 FY25 · $349K total
| Segment | Share | Revenue | YoY | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 58.2% | $203K | +113.7% | $79K | $67K | $7K | $95K |
| CANADA | 41.8% | $146K | -32.7% | $45K | $104K | $33K | $217K |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.